DESTINY-S: Attitudes of physicians toward disability and treatment in malignant MCA infarction

Neurocritical Care

Volumn 21, Issue 1, 2014, Pages 27-34

  Neugebauer, Hermann ^a   Creutzfeldt, Claire J ^b   Hemphill III, J Claude ^c   Heuschmann, Peter U ^d,e   Jüttler, Eric ^a,f  

^a Rehabilitationskrankenhaus Ulm gGmbH   (Germany)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Decompressive hemicraniectomy; Disability; Malignant middle cerebral artery infarction; Outcome

Indexed keywords

ADULT; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBRAL ARTERY DISEASE; CROSS-SECTIONAL STUDY; DECOMPRESSION SURGERY; DECOMPRESSIVE HEMICRANIECTOMY; DISABILITY; FEMALE; HUMAN; INTERNATIONAL COOPERATION; MALE; MALIGNANT MIDDLE CEREBRAL ARTERY INFARCTION; MEDICAL DECISION MAKING; MEDICINE; OUTCOME ASSESSMENT; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; RANKIN SCALE; SEX DIFFERENCE; WORK EXPERIENCE; ADVERSE EFFECTS; ATTITUDE TO HEALTH; CLINICAL TRIAL; DECOMPRESSIVE CRANIECTOMY; INFARCTION, MIDDLE CEREBRAL ARTERY; MULTICENTER STUDY; PHYSICIAN; PSYCHOLOGY; STANDARDS; TREATMENT OUTCOME;

ADULT; DECOMPRESSIVE CRANIECTOMY; DISABILITY EVALUATION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; PHYSICIANS; TREATMENT OUTCOME;

EID: 84904110594     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-014-9956-0     Document Type: Article

References (36)

1. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol. 1996;53:309-15. (Pubitemid 26110085)
2. Hofmeijer J, Kapelle LJ, Algra A, et al. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol. 2009;8:326-33.
3. Jüttler E, Schwab S, Schmiedek P, et al. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): a randomised, controlled trial. Stroke. 2007;38:2518-25. (Pubitemid 47329631)
4. Vahedi K, Vicaut E, Mateo J, et al. Sequential-design, multicenter, randomised, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke. 2007;38:2506-17. (Pubitemid 47329630)
5. Vahedi K, Hofmeijer J, Juettler E, et al. Early decompressive surgery in malignant middle cerebral artery infarction: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6:215-22. (Pubitemid 46237760)
6. Puetz V, Campos CR, Eliasziw M, Hill MD, Demchuk AM. Calgary Stroke Program. Assessing the benefits of hemicraniectomy: what is a favourable outcome? Lancet Neurol. 2007;6:580. (Pubitemid 46921050)
7. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25:457-507.
8. Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870-947.
9. Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-7.
10. No authors listed. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333: 1581-7.
11. Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127-37. (Pubitemid 351679599)
12. Vahedi K, Hofmeijer J, Juettler E, et al. Assessing the benefits of hemicraniectomy: what is a favourable outcome? - Authors's reply. Lancet Neurol. 2007;6:580-1. (Pubitemid 46921051)
13. New PW, Buchbinder R. Critical appraisal and review of the Rankin scale and its derivatives. Neuroepidemiology. 2006;26:4-15. (Pubitemid 41797932)
14. World Health Organization. International Classification of Functioning, Disability and Health (ICF). October 2005; Geneva.
15. Albrecht GL, Devlieger PJ. The disability paradox: high quality of life against all odds. Soc Sci Med. 1999;48:977-88. (Pubitemid 29147322)
16. Creutzfeldt CJ, Holloway RG. Treatment decisions after severe stroke: uncertainty and biases. Stroke. 2012;43:3405-8.
17. Quill TE, Holloway RG. Evidence, preferences, recommendations - finding the right balance in patient care. N Engl J Med. 2012;366:1653-5.
18. Nakagawa K, Bianchi MT, Nakagawa SS, Sorond FA. Aggressive care after a massive stroke in young patients: is that what they want? Neurocrit Care. 2010;13:118-22.
19. Walz B, Zimmermann C, Böttger S, Haberl RL. Prognosis of patients after hemicraniectomy in malignant middle cerebral artery infarction. J Neurol. 2002;249:1183-90. (Pubitemid 35025091)
20. Woertgen C, Erban P, Rothoerl RD, Bein T, Horn M, Brawanski A. Quality of life after decompressive craniectomy in patients suffering from supratentorial brain ischemia. Acta Neurochir (Wien). 2004;146:691-5. (Pubitemid 38856615)
21. Kiphuth IC, Köhrmann M, Lichy C, Schwab S, Huttner HB. Hemicraniectomy for malignant middle cerebral artery infarction: retrospective consent to decompressive surgery depends on functional long-term outcome. Neurocrit Care. 2010;13:380-4.
22. Benejam B, Sahuquillo J, Poca MA, et al. Quality of life and neurobehavioral changes in survivors of malignant middle cerebral artery infarction. J Neurol. 2009;256:1126-33.
23. von Sarnowski B, Kleist-Welch Guerra W, Kohlmann T, et al. Long-term health-related quality of life after decompressive hemicraniectomy in stroke patients with life-threatening space-occupying brain edema. Clin Neurol Neurosurg. 2012;114:627-33.
24. Leonhardt G, Wilhelm H, Doerfler A, et al. Clinical outcome and neuropsychological deficits after right decompressive hemicraniectomy in MCA infarction. J Neurol. 2002;249:1433-40. (Pubitemid 35217668)
25. Foerch C, Lang JM, Krause J, et al. Functional impairment, disability, and quality of life outcome after decompressive hemicraniectomy in malignant middle cerebral artery infarction. J Neurosurg. 2004;101:248-54. (Pubitemid 38971000)
26. Vahedi K, Benoist L, Kurtz A, et al. Quality of life after decompressive craniectomy for malignant middle cerebral artery infarction. J Neurol Neurosurg Psychiatry. 2005;76:1181-2. (Pubitemid 41081302)
27. Gupta R, Connolly ES, Mayer S, Elkind MS. Hemicraniectomy for massive middle cerebral artery territory infarction: a systematic review. Stroke. 2004;35:539-43. (Pubitemid 38174445)
28. Weil AG, Rahme R, Moumdjian R, Bouthillier A, Bojanowski MW. Quality of life following hemicraniectomy for malignant MCA territory infarction. Can J Neurol Sci. 2011;38:434-8.
29. Erban P, Woertgen C, Luerding R, Bogdahn U, Schlachetzki F, Horn M. Long-term outcome after hemicraniectomy for space occupying right hemispheric MCA infarction. Clin Neurol Neurosurg. 2006;108:384-7.
30. Rahme R, Zuccarello M, Kleindorfer D, Adeoye OM, Ringer AJ. Decompressive hemicraniectomy for malignant middle cerebral artery territory infarction: is life worth living? J Neurosurg. 2012;117:749-54.
31. McKenna A, Wilson CF, Caldwell SB, Curran D. Functional outcomes of decompressive hemicraniectomy following malignant middle cerebral artery infarctions: a systematic review. Br J Neurosurg. 2012;26:310-5.
32. Bardutzky J, Schwab S. Antiedema therapy in ischemic stroke. Stroke. 2007;38:3084-94. (Pubitemid 350035708)
33. Rabinstein AA, Hemphill JC. Prognosticating after severe acute brain disease - Science, art, and biases. Neurology. 2010;74:1086-7.
34. Creutzfeldt CJ, Becker KJ, Weinstein JR, et al. Do-not-attempt- resuscitation orders and prognostic models for intraparenchymal hemorrhage. Crit Care Med. 2011;39:158-62.
35. Ubel PA, Loewenstein G, Schwarz N, Smith D. Misimagining the unimaginable: the disability paradox and health care decision making. Health Psychol. 2005;24:S57-62. (Pubitemid 41099126)
36. Gilbert DT, Pinel EC, Wilson TD, Blumberg SJ, Wheatley TP. Immune neglect: a source of durability bias in affective forecasting. J Pers Soc Psychol. 1998;75:617-38. (Pubitemid 127455698)